Relative Strength Chart Brainstorm Cell Therapeutics Inc. Deutsche Boerse AG
Equities
GHDN
US10501E2019
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4655 EUR | +6.89% | +9.53% | +102.39% |
Apr. 17 | Brainstorm Cell Therapeutics Inc. Announces Step Down of Stacy Lindborg as Co-CEO, Effective as of May 9, 2024 | CI |
Apr. 17 | Brainstorm Cell Therapeutics Inc. Announces Management Changes | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
BRAINSTORM CELL THERAPEUTICS INC. | Other Biotechnology & Medical Research | +6.89% | +9.53% | +102.39% | -81.08% | -86.15% | 35.26M | - | - | - |
- Stock Market
- Equities
- BCLI Stock
- GHDN Stock
- Charts Brainstorm Cell Therapeutics Inc.
- Relative Strength Chart